Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Shares Traded Last Trade
  -3.00 -5.26% 54.00 58,845 08:38:05
Bid Price Offer Price High Price Low Price Open Price
53.00 55.00 57.00 54.00 57.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.06 -20.38 -55.00 30
Last Trade Time Trade Type Trade Size Trade Price Currency
08:43:48 O 3,467 53.72 GBX

Genedrive (GDR) Latest News (1)

More Genedrive News
Genedrive Investors    Genedrive Takeover Rumours

Genedrive (GDR) Discussions and Chat

Genedrive Forums and Chat

Date Time Title Posts
28/11/202023:22Genedrive. A Game Changer for Global Covid 19 Testing Market?2,744
27/11/202020:29Genedrive PLC (GDR) Covid19 Diagnostics750
11/9/202005:27Genedrive (GDR) One to Watch 919
22/6/202019:45The New Genedrive Thread1
23/4/202015:50Still waiting....161

Add a New Thread

Genedrive (GDR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Genedrive trades in real-time

Genedrive (GDR) Top Chat Posts

Genedrive Daily Update: Genedrive Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 57p.
Genedrive Plc has a 4 week average price of 44p and a 12 week average price of 44p.
The 1 year high share price is 299p while the 1 year low share price is currently 6.50p.
There are currently 56,464,752 shares in issue and the average daily traded volume is 968,281 shares. The market capitalisation of Genedrive Plc is £32,184,908.64.
amaretto1: AVCT test ... same time lines .... same test !!GDR mkt cap compared to there's ??Insane.Never mind everything else going on with GDR ...Can Any one else can explain this !!!!
furion786: the government announcing £40Bn to testing suggests that they still believe it is necessary. But must admit it really has hit these stocks hard. God knows why its taking so long to get this approval. My plan was get FDA hopefully see a decent rise take some profits place it into Carnival and RR but this has just wrecked that. missed the ship on all counts lol. i hope he has contracts lined up cos when if we get this approval he will need to get them out quick and fast but i do not think we will see a big rise in share price now.. Markets has set its stall for vaccines and stocks that mean getting back to normality not much interest remains in GDR ODX etc IMO. GLA
master rsi: Only one way for the share price so far. ---------- Covid: Antibodies 'fall rapidly after infection' By James Gallagher - Health and science correspondent for the BBC Levels of protective antibodies in people wane "quite rapidly" after coronavirus infection, say researchers. Antibodies are a key part of our immune defences and stop the virus from getting inside the body's cells. The Imperial College London team found the number of people testing positive for antibodies has fallen by 26% between June and September. They say immunity appears to be fading and there is a risk of catching the virus multiple times. More than 350,000 people in England have taken an antibody test as part of the REACT-2 study so far. In the first round of testing, at the end of June and the beginning of July, about 60 in 1,000 people had detectable antibodies. But in the latest set of tests, in September, only 44 per 1,000 people were positive. It suggests the number of people with antibodies fell by more than a quarter between summer and autumn.....
john henry: I absolutely know the difference that's why NCYT is my favoured Covid test stock and I advised switching from GDR into NCYT when NCYT was a tad over £4 and GDR was 150pThe rest is history GDR down 33% NCYT up 175%
pauliewonder: Fantastic RNS. The potential at GDR is astonishing and we should be multiple times higher than the current share price in my opinion
amaretto1: I originally bought here and NCYT ... they nearly the same share price at the time.GDR 20 years of diagnostic business Talk about .. if you backed the wrong horse ... unbelievable Jeff :-)
swerves1: Beware cross marketing by any poster with no history ......notice their MTPH tip today is down already!GDR is the one to be in now......massive news and share price rerate expected soon......
amaretto1: Mmm .. another better day Plenty to go here, if everything goes to plan .. your looking treble this share price other play in this sector doing well, free ride over there.Bought back original holding SNG mainly for less than my previous selling price....So a very good week for mwah Onwards and upwards !!
mufprat: Tried to top up earlier whilst the share price was still flat - couldn't buy even 1000 shares. I read that sort of comment all the time and think, get a better broker. However to keep costs down the majority of brokers use the RSP and if the MMs aren't displaying the stock, it's just not there to buy. I should have called and dealt over the phone, but was distracted. Moral of the story with this share, if you want to buy and sell, just use the phone, the MM is obligated to offer a price up to the EMS (1500 shares). Not the case when using the RSP.
fuji99: GDR is the only hope for fast testing. So far we have nothing that can cut waiting time as most tests are lab based. Once approved, the share price will go a long way. £3 is my first stop.
Genedrive share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 09:01:52